期刊
JOURNAL OF VIROLOGY
卷 86, 期 4, 页码 2197-2211出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/JVI.05047-11
关键词
-
类别
资金
- NCI NIH HHS [R01 CA075922, CA132638, CA75922] Funding Source: Medline
- NCRR NIH HHS [RR018107, RR00163] Funding Source: Medline
Kaposi's sarcoma-associated herpesvirus and rhesus macaque rhadinovirus (RRV), two closely related gammaherpesviruses, are unique in their expression of viral homologs of cellular interferon regulatory factors (IRFs), termed viral IRFs (vIRFs). To assess the role of vIRFs during de novo infection, we have utilized the bacterial artificial chromosome clone of wild-type RRV17577 (WTBAC RRV) to generate a recombinant virus with all 8 of the vIRFs deleted (vIRF-ko RRV). The infection of primary rhesus fibroblasts and peripheral blood mononuclear cells (PBMCs) with vIRF-ko RRV resulted in earlier and increased induction of type I interferon (IFN) (IFN-alpha/beta) and type II IFN (IFN-gamma). Additionally, plasmacytoid dendritic cells maintained higher levels of IFN-alpha production in PBMC cultures infected with vIRF-ko RRV than in cultures infected with WTBAC RRV. Moreover, the nuclear accumulation of phosphorylated IRF-3, which is necessary for the induction of type I IFN, was also inhibited following WTBAC RRV infection. These findings demonstrate that during de novo RRV infection, vIRFs are inhibiting the induction of IFN at the transcriptional level, and one potential mechanism for this is the disruption of the activation and localization of IRF-3.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据